retatrutide vs tirzepatide which is better vs. Retatrutide: Key Differences Explained RETATRUTIDE: A Medication for Diabetes

The Phase II trial for retatrutide reported some adverse events: A large percentage of participants (73% to 94%) reported side effects while taking retatrutide, especially in the higher 8-mg and 12-mg groups

While side effects like nausea are common, theyre usually mild and temporary

With major pharmaceutical companies recently withdrawing from the UK and concern about the current reimbursement model, according to the Financial Times, the government is set to alter the pricing structure

The gap narrows significantly at higher doses

Prioritize Protein: Maintaining muscle mass is vital for metabolic health

some clinicians may start at the lower end (0.2 mg) and adjust based on IGF-1 levels and clinical response